DK1330428T3 - Faste præparater til oral administration indeholdende ikke-hygroskopiske salte af L-carnitin og alkanoyl-L-carnitiner med taurinchlorid - Google Patents

Faste præparater til oral administration indeholdende ikke-hygroskopiske salte af L-carnitin og alkanoyl-L-carnitiner med taurinchlorid

Info

Publication number: DK1330428T3
Authority: DK; Denmark
Prior art keywords: carnitine; alkanoyl; oral administration; carnitines; hygroscopic salts
Prior art date: 2000-10-31

Application number

DK01976633T

Other languages

English (en)

Inventor

Maria Ornella Tinti

Original Assignee

Sigma Tau Ind Farmaceuti

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-31

Filing date

2001-09-28

Publication date

2006-04-18

2001-09-28 Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti

2006-04-18 Application granted granted Critical

2006-04-18 Publication of DK1330428T3 publication Critical patent/DK1330428T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/08—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
- C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Hematology (AREA)
Botany (AREA)
Mycology (AREA)
Obesity (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Nutrition Science (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Neurosurgery (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Child & Adolescent Psychology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Fodder In General (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

DK01976633T 2000-10-31 2001-09-28 Faste præparater til oral administration indeholdende ikke-hygroskopiske salte af L-carnitin og alkanoyl-L-carnitiner med taurinchlorid DK1330428T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT2000RM000567A IT1317924B1 (it)	2000-10-31	2000-10-31	Composizioni solide atte alla somministrazione orale comprendenti salinon igroscopici della l-carnitina e delle alcanoil l-carnitine con

Publications (1)

Publication Number	Publication Date
DK1330428T3 true DK1330428T3 (da)	2006-04-18

Family

ID=11454973

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01976633T DK1330428T3 (da)	2000-10-31	2001-09-28	Faste præparater til oral administration indeholdende ikke-hygroskopiske salte af L-carnitin og alkanoyl-L-carnitiner med taurinchlorid

Country Status (25)

Country	Link
US (1)	US7858820B2 (da)
EP (1)	EP1330428B1 (da)
JP (1)	JP4181406B2 (da)
KR (1)	KR100764155B1 (da)
CN (1)	CN1219748C (da)
AT (1)	ATE312810T1 (da)
AU (2)	AU9589301A (da)
BR (1)	BRPI0115019B1 (da)
CA (1)	CA2427482C (da)
CY (1)	CY1106062T1 (da)
CZ (1)	CZ302802B6 (da)
DE (1)	DE60115944T2 (da)
DK (1)	DK1330428T3 (da)
ES (1)	ES2253430T3 (da)
HK (1)	HK1061230A1 (da)
HU (1)	HU229989B1 (da)
IT (1)	IT1317924B1 (da)
MX (1)	MXPA03003799A (da)
NZ (1)	NZ525333A (da)
PL (1)	PL205801B1 (da)
RU (1)	RU2270191C2 (da)
SI (1)	SI1330428T1 (da)
SK (1)	SK287133B6 (da)
WO (1)	WO2002036543A1 (da)
ZA (1)	ZA200303328B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102005031705A1 (de) *	2005-07-05	2007-01-18	Henkel Kgaa	Mittel, enthaltend L-Carnitin oder L-Carnitinderivate und mindestens eine weitere Substanz ausgewählt aus Taurin und dessen Derivaten und mindestens einem Wirkstoff, erhältlich aus Pflanzen der Gattung Echinacea
KR101007927B1 (ko)	2008-12-24	2011-01-14	주식회사 셀트리온제약	시부트라민-ｌ-카르니틴 다이술폰산염, 이의 제조방법 및 이를 포함하는 약제학적 조성물
JP5451558B2 (ja) *	2010-08-27	2014-03-26	シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ	美容活性成分の送達に有用なゲル
CN104276986B (zh) *	2013-07-12	2016-07-06	辽宁科硕营养科技有限公司	左旋肉碱牛磺酸盐的制备方法
JP6473352B2 (ja) *	2015-03-10	2019-02-20	利幸糸井	虚血性疾患治療薬
CN107325013B (zh) *	2016-04-28	2019-04-12	辽宁科硕营养科技股份有限公司	一种合成甘氨酸丙酰左旋肉碱盐酸盐的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3463261D1 (en) *	1983-12-28	1987-05-27	Sigma Tau Ind Farmaceuti	Salts of l-carnitine and alkanoyl l-carnitines and process for preparing same
CA2030310A1 (en) *	1989-12-22	1991-06-23	Ronald E. Macleay	Derivatives of n-hals-substituted amic acid hydrazides
IT1291126B1 (it) *	1997-04-01	1998-12-29	Sigma Tau Ind Farmaceuti	Composizioni solide atte alla somministrazione orale comprendenti sali non igroscopici della l-carnitina e delle alcanoil l-carnitine
IT1306147B1 (it) *	1999-05-28	2001-05-30	Biosalts Srl	Derivati di principi attivi ad attivita' terapeutica e/o nutrizionalee composizioni atte alla somministrazione orale contenenti tali

2000
- 2000-10-31 IT IT2000RM000567A patent/IT1317924B1/it active
2001
- 2001-09-28 AT AT01976633T patent/ATE312810T1/de active
- 2001-09-28 SK SK501-2003A patent/SK287133B6/sk not_active IP Right Cessation
- 2001-09-28 EP EP01976633A patent/EP1330428B1/en not_active Expired - Lifetime
- 2001-09-28 CN CNB018182941A patent/CN1219748C/zh not_active Expired - Lifetime
- 2001-09-28 CA CA2427482A patent/CA2427482C/en not_active Expired - Fee Related
- 2001-09-28 US US10/415,472 patent/US7858820B2/en not_active Expired - Lifetime
- 2001-09-28 AU AU9589301A patent/AU9589301A/xx active Pending
- 2001-09-28 DE DE60115944T patent/DE60115944T2/de not_active Expired - Lifetime
- 2001-09-28 DK DK01976633T patent/DK1330428T3/da active
- 2001-09-28 MX MXPA03003799A patent/MXPA03003799A/es active IP Right Grant
- 2001-09-28 ES ES01976633T patent/ES2253430T3/es not_active Expired - Lifetime
- 2001-09-28 AU AU2001295893A patent/AU2001295893B2/en not_active Ceased
- 2001-09-28 JP JP2002539304A patent/JP4181406B2/ja not_active Expired - Fee Related
- 2001-09-28 RU RU2003116133/04A patent/RU2270191C2/ru active
- 2001-09-28 SI SI200130462T patent/SI1330428T1/sl unknown
- 2001-09-28 WO PCT/IT2001/000503 patent/WO2002036543A1/en active IP Right Grant
- 2001-09-28 NZ NZ525333A patent/NZ525333A/en not_active IP Right Cessation
- 2001-09-28 KR KR1020037005596A patent/KR100764155B1/ko active IP Right Grant
- 2001-09-28 HU HU0302294A patent/HU229989B1/hu not_active IP Right Cessation
- 2001-09-28 BR BRPI0115019A patent/BRPI0115019B1/pt not_active IP Right Cessation
- 2001-09-28 CZ CZ20031041A patent/CZ302802B6/cs not_active IP Right Cessation
- 2001-09-28 PL PL364823A patent/PL205801B1/pl unknown
2003
- 2003-04-30 ZA ZA200303328A patent/ZA200303328B/en unknown
2004
- 2004-06-16 HK HK04104342A patent/HK1061230A1/xx not_active IP Right Cessation
2006
- 2006-01-19 CY CY20061100074T patent/CY1106062T1/el unknown

Also Published As

Publication number	Publication date
US7858820B2 (en)	2010-12-28
RU2270191C2 (ru)	2006-02-20
US20040024061A1 (en)	2004-02-05
BR0115019A (pt)	2003-12-23
HK1061230A1 (en)	2004-09-10
DE60115944D1 (de)	2006-01-19
KR20030059211A (ko)	2003-07-07
JP2004513107A (ja)	2004-04-30
JP4181406B2 (ja)	2008-11-12
AU2001295893B2 (en)	2006-11-30
CA2427482C (en)	2010-04-27
ZA200303328B (en)	2004-03-09
SI1330428T1 (sl)	2006-04-30
CN1219748C (zh)	2005-09-21
HU229989B1 (hu)	2015-04-28
KR100764155B1 (ko)	2007-10-08
ATE312810T1 (de)	2005-12-15
NZ525333A (en)	2004-06-25
BRPI0115019B1 (pt)	2015-10-06
DE60115944T2 (de)	2006-06-29
CN1473144A (zh)	2004-02-04
WO2002036543A1 (en)	2002-05-10
PL364823A1 (en)	2004-12-27
PL205801B1 (pl)	2010-05-31
IT1317924B1 (it)	2003-07-15
ES2253430T3 (es)	2006-06-01
CZ20031041A3 (cs)	2003-08-13
CY1106062T1 (el)	2011-06-08
EP1330428B1 (en)	2005-12-14
MXPA03003799A (es)	2004-04-20
ITRM20000567A0 (it)	2000-10-31
CA2427482A1 (en)	2002-05-10
HUP0302294A3 (en)	2005-05-30
EP1330428A1 (en)	2003-07-30
HUP0302294A2 (hu)	2003-10-28
SK5012003A3 (en)	2003-11-04
CZ302802B6 (cs)	2011-11-16
AU9589301A (en)	2002-05-15
SK287133B6 (sk)	2010-01-07
ITRM20000567A1 (it)	2002-05-01

Publication	Publication Date	Title
ATE262348T1 (de)	2004-04-15	Mittel zur verabreichung von antigenen
CY1112139T1 (el)	2015-11-04	Μια φαρμακευτικη συνθεση περιλαμβανουσα κρυσταλλικη ριτοναβιρη μορφη ιι και ενα παρασκευασμα εξ αυτης
DK1299348T3 (da)	2008-07-28	Forbindelser og sammensætninger til levering af aktive midler
DK0760677T3 (da)	2001-12-31	Farmaceutisk præparat omfattende glucagon
EA200201271A1 (ru)	2003-04-24	Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
DK1383752T3 (da)	2005-10-17	Deutererede 3-piperidinopropiophenoner samt lægemidler indeholdende disse forbindelser
BR0214343A (pt)	2004-09-14	Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
EA200400073A1 (ru)	2004-08-26	Пирролопиримидины как ингибиторы протеинкиназы
TR200002299T2 (tr)	2000-11-21	Epotilon kompozisyonları.
TR200002179T2 (tr)	2001-07-23	Kristalin teriparatid.
DK1185253T3 (da)	2004-04-05	Oralt præparat til indgivelse af en fast kombination af tramadol og diclofenac
NO20062508L (no)	2006-07-31	Administrering av levodopa og karbidopa
EA200000759A1 (ru)	2001-04-23	Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
EA200100298A1 (ru)	2001-08-27	ФАРМАЦЕВТИЧЕСКИЕ ПРЕПАРАТЫ С РЕГУЛИРУЕМЫМ ВЫСВОБОЖДЕНИЕМ, СОДЕРЖАЩИЕ ИНГИБИТОР cGMP-ФОСФОДИЭСТЕРАЗЫ-5
CY1111470T1 (el)	2015-08-05	Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
UY27852A1 (es)	2003-12-31	Difenilazatidinonas cationicamente sustituidas, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso.
BR0306928A (pt)	2004-11-09	Composições farmacêuticas estáveis compreendendo inibidores de enzimas conversoras de angiotensina (ace)
DK1330428T3 (da)	2006-04-18	Faste præparater til oral administration indeholdende ikke-hygroskopiske salte af L-carnitin og alkanoyl-L-carnitiner med taurinchlorid
ES2422081T3 (es)	2013-09-06	Péptido Ser-Ser-Ser-Arg y sus utilizaciones medicinales
DK0634396T3 (da)	1999-07-05	Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
DK1208078T3 (da)	2004-06-14	Ikke-hygroskopiske salte af aktive bestanddele der har terapeutiske og/eller ernæringsmæssige aktiveteter og sammensætninger til oral indgivelse der indeholder disse
EA200201024A1 (ru)	2003-02-27	Фармацевтические композиции, содержащие олигосахариды, и их получение
PT1093451E (pt)	2003-12-31	Composicoes solidas adequadas para administracao oral contendo sais nao-higroscopicos de l-carnitina e alcanoil-l-carnitinas
TR200102584T2 (tr)	2002-03-21	Antrasiklinlerin L-arabino-disakaridleri, hazìrlanmalarì iin usller, bunlarì ieren farmasotik kompozisyonlar
RU2000105081A (ru)	2001-12-27	Применение препарата "эсвицин" для лечения ревматоидного артрита